



SHOCKS BY MEANS OF 
TEMPORARY EPICARDIAL 
WIRE ELECTRODES 
Sustained atrial fibrillation is very common after cardiac surgical proce- 
dures. We hypothesized that atrial defibrillation could be accomplished 
consistently and safely by means of low-energy shocks delivered by tempo- 
rary stainless steel wire electrodes placed at the time of the operation. 
Sterile pericarditis was created in five mongrel dogs (20.9 - 2.1 kg), and 
pairs of standard temporary stainless teel wire electrodes were placed on 
the right atrial appendage, on Bachmann's bundle, and on the right 
ventricular apex for pacing, sensing, and recording. Temporary stainless 
steel wire electrodes, insulated except for the distal 6 cm and used to deliver 
defibrillation shocks, were placed adjacent o both atrial free walls and 
secured to the pericardium. All electrodes were brought out through the 
skin, and the sternotomy was Closed. Dogs were tested in the conscious tate 
on postoperative day 2. Sustained atrial fibrillation was induced by rapid 
atrial pacing. A customized software program was used to control the 
defibrillator, which delivered R wave-synchronous biphasic shocks to the 
atria through the temporary defibrillation electrodes. The shock intensity 
began at 50 volts and was increased by 10-volt increments until atrial 
fibrillation was terminated. Atrial fibrillation was terminated in all dogs at 
112 - 7 volts, with an energy of 0.42 -+ 0.07 joule and an impedance of 
67.8 -+ 4 ohms (all values mean -+ standard error of the mean). The mean 
percent success for atrial defibrillation at this minimal threshold was 49%. 
Thus at low-threshold voltages atrial fibrillation could be terminated with 
every other shock. A 25% increase in the minimal threshold voltage 
improved the conversion rate to 73% (mean energy 0.66 -+ 0.19 joule and 
mean impedance of 67 -+ 3.8 ohms). No complications were detected with 
the use of the electrodes or after their removal on the seventh postoperative 
day. One instance of electrode migration on the right atrial free wall was 
detected by roentgenography, but this did not adversely affect atrial 
defibrillation threshold. No ventricular arrhythmias or hemodynamic 
complications were noted during shock delivery. We conclude that success- 
ful conversion of atrial fibrillation to sinus rhythm can be achieved 
consistently with shock energies below 0.5 joule delivered with temporary 
epicardial defibrillation wire electrodes in this canine pericarditis model. 
These results suggest hat this approach to the management of sustained 
atria ! tachyarrhythmias has Considerable promise in the management of
atrial fibrillation in patients who have had cardiac operations. (J TrIORAC 
CARDIOVASC SuRG 1996;111:392-8) 
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A trial tachyarrhythmias re the most common type of rhythm disturbance seen after cardiac 
surgical procedure s. The prevalence of atrial ar- 
rhythmias after cardiac operations varies between 
25% and 50%) -4 A recent large series documented 
the prevalence of atrial arrhythmias after isolated 
coronary bypass operations to be more than 30%, 
and as the complexity of the procedures increased, 
the prevalence of atrial rhythm disturbances rose as 
high as 90%. 1 The clinical sequelae from postoper- 
ative atrial arrhythmias range from self-limited epi- 
sodes of little clinical consequence to congestive 
heart failure causing significant patient morbidity. 
Morbidity from atrial tachyarrhythmias includes 
hemodynamic impairment from loss of atrial contri5 
bution to cardiac output, increased risk of thrombo- 
embolic stroke, and increased length of hospitaliza- 
tion. The prevalence of these rhythm disturbances 
and their impact on patient morbidity and hospital 
cost has prompted several studies of perioperative 
pharmacologic prophylaxis to prevent atrial tachy- 
arrhythmias from developing during the postopera- 
tive period, s-7 
Management of atrial arrhythmias has included 
the correction of underlying electrolyte abnormali- 
ties. pharmacologic therapy, rapid atrial pacing, and 
direct-current cardioversion. Pharmacologic therapy 
has centered around the use of medications for both 
ventricular ate control and cardioversion. Direct- 
current cardioversion has traditionally required the 
use of anesthetics to provide adequate pain control 
because of the high energy (50 to 360 joules) 
required for transthoracic ardioversion. Rapid 
atrial pacing through temporary epicardial wire 
electrodes is used to treat classic (type I) atrial 
flutter and some forms of atrial tachycardia, but it 
has no role in the treatment of atrial fibrillation or 
type II atrial flutter. 8
Temporary epicardial stainless steel wire elec- 
trodes have long been used to diagnose and treat a 
variety of rhythm disturbances after cardiac surgical 
procedures. The use of temporary wire electrodes 
for these purposes was initially reported in the 1960s 
by Harris and associates. 9' 10 The clinical utility of 
temporary electrodes in both the atrial and ventric- 
ular positions has been documented. 8'11"12 This 
pilot study was designed to investigate extending the 
role of temporary stainless teel wire electrodes for 
the purpose of defibrillating the atria with low- 
energy shocks. We hypothesized that effective atrial 
defibrillation could be accomplished safely and reli- 
ably with very,low-energy shocks delivered through 
temporary wire electrodes placed adjacent o the 
left and right atria. The previously reported success 
Of atrial defibrillation achieved with low-energy 
shocks delivered by endocardial electrodes Place d in 
the coronary sinus and right atrial appendage in 
animal models encouraged us to pursue this hypothr 
esis. 13-16 
Materials and methods 
All animals used in this study received humane care in 
compliance with the "Principles of Laboratory Animal 
Care" formulated by the National Society for Medical 
Research and the "Guide for the Care and Use of 
Laboratory Animals" prepare d by the Institute of Labo- 
ratory Animal Resources and published by the National 
Institutes of Health (NIH Publication No. 86-23, revised 
1985). 
Operative technique. Five mongrel dogs weighing an 
average of 20.9 kg were studied. General anesthesia was 
induced with thi0pental (30 mg/kg) and maintained with 
1% halothane and nitrous oxide delivered through an 
endotracheal tube. A median sternotomy was accom- 
plished with an oscillating saw, and a pericardial cradle 
was created. Pairs of stainless teel temporary wire eleC- 
trodes (0-Flexon, Davis & Geck, Danbury , Conn.) coated 
with Teflon polytetrafluoroethy|ene were placed on the 
right atrial appendage, Bachmann's bundle, and at the 
right ventrieular apex for pacing, sensing , and recording. 
All electrodes were brought out through the skin through 
separate stab wounds on the flanks of the animals and 
were secured with nonabsorbable suture. Cust0m,made 
defibrillation wire electrodes with an outer diameter of 
0.016 inch and insulated except for the distal 6 cm 
(InControl, Incorporated, Redmond, Wash.) (Fig. 1) were 
woven into the pericardium with the exposed wire adja- 
cent to the atrial epieardial surface. The right atrial 
electrode was secured parallel to the course of the supe- 
rior and inferior venae cavae along the right atrial free 
Wall, and the left atrial electrode was secured parallel and 
superior tO the course of the coronary Sinus. Thus the bulk 
of the atrial muscle mass was between the two exposed 
surfaces of the wire electrodes. Electrode position is 
demonstrated in Fig. 2. Each of these electrodes was also 
externalized through a stab wound in the flank and 
secured with nonabsorbable suture. Right and left atrial 
surfaces were then dusted with sterile talcum powder in 
the manner described by Pag6 and associates, 17with care 
taken not to apply the powder to the surfaces of the 
ventricles. The pericardium was then reapproximated with 
nonabsorbable suture, the sternotomy was closed in stan- 
dard fashion , and the dog was allowed to recover. A 
postoperative chest x-ray film was obtained in all dogs. All 
animals received perioperative antibiotic administration 
with parenteral cefazolin (1000 rag). Postoperative antibi- 
otic treatment consisted of enteraliy administered amoxi- 
cillin-clavulanic acid (250 nag twice a day). Postoperative 
pain was managed with subcutaneously administered bu- 
prenorphine (0.03 mg twice a day). 
Atrial defibrillation studies. The efficacy and safety of 
atrial defibrillation effected with the temporary defibrilla- 
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Stainless Steel Wire Electrode 
(6 cm) 
Insula~d Portion of Electrode 
(0.016" CID.) 
Polypropylene Suture 
Fig. 1. Diagram of a stainless teel electrode used 
Fig. 2. Location of temporary stainless steel defibrillation 
electrodes in the pericardial sac when the heart is viewed 
anteriorly. The dotted line represents the course of the 
electrode running just above the level of the coronary 
sinus. 
tion wire electrodes were evaluated on postoperative day 
2. An anteroposterior chest x-ray film was obtained to 
verify wire electrode positions before testing by compar- 
ing the film with one taken after the operation. The 
animals were tested in a conscious but sedated state 
for atrial defibrillation. O.D., Outer diameter. 
(xylazine, 0.2 mg/kg) for this portion of the study. Elec- 
trocardiogram leads I, II, and III and electrograms from 
the right atrial appendage, right ventricular apex, and 
Bachmann's bundle were monitored and recorded on a 
switched-beam oscilloscopic recorder (model VR-16, 
Electronics for Medicine, Pleasantville, N.Y.). Sustained 
atrial fibrillation, defined as atrial fibrillation lasting at 
least 5 minutes, was induced by rapid atrial pacing through 
the right atrial appendage electrodes. A customized soft- 
ware program was used to control the defibrillation (In- 
Control), which delivered an R wave-synchronized bipha- 
sic shock to the atria through the bare portion of the 
defibrillation wire electrodes. Shock intensity began at 50 
volts (known to be ineffective 16) and was increased in 
10-volt increments until atrial fibrillation was terminated. 
Twenty shocks at this voltage were then tested to deter- 
mined the percent of successful conversion to sinus 
rhythm. If the percent conversion was between 10% and 
90%, this value was designated the minimum threshold 
voltage. If the percent conversion was below 10% or above 
90%, the voltage was raised or lowered, respectively, and 
testing was repeated until the percent success fell into the 
latter range. Shock intensities that were approximately 
25% higher than the minimum threshold voltage were 
then tested in a similar 20-shock protocol to determine 
whether percent conversion to sinus rhythm would in- 
crease. 
On the seventh postoperative day, the defibrillation 
wire electrodes were removed from all dogs while they 
were under a general anesthetic. During this time, cardiac 
rhythm was monitored continuously with an electrocar- 
diogram in all animals and blood pressure with an indwell- 
ing femoral artery catheter connected to a strain gauge 
and amplifier. The animals were observed for signs of 
hemodynamic nstability or arrhythmias for half an hour 
after the defibrillation wire electrodes were removed, and 
then they were put to death. All hearts were excised and 
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Atrial Fibrillation Shock Sinus Rhythm 
Fig. 3. An example of atrial defibrillation i  the canine model of sterile pericarditis with stainless teel 
temporary atrial defibrillation wires. RAA, Right atrial appendage; RVA, right ventricular apex. 
inspected for evidence of trauma related to the defibril- 
lation wire electrodes. 
Results 
After sustained atrial fibrillation was induced, the 
atria were successfully defibrillated in each of the 
five dogs. A representative example is shown in Fig. 
3. Migration of a defibrillation wire electrode was 
noted in one animal, probably because of improper 
weaving of the wire into the pericardium. In this 
animal, only the studies to determine the minimum 
threshold voltage were performed. The animal was 
then put to death after the minimum threshold 
voltage had been determined, and the pericardium 
was inspected for wire electrode migration. Both 
defibrillator wire electrodes had been displaced to a 
minimal extent, but atrial defibrillation had been 
successfully accomplished nonetheless. 
No evidence of trauma from the multiple defibril- 
lations was noted on either the right or left atrium 
after the hearts were excised. All sets of defibrillat- 
ing wire electrodes were removed easily and without 
complication by simply applying gentle traction at 
the insertion site in the same manner that is used to 
remove a temporary cardiac pacing wire. Hemody- 
namic criteria indicated no evidence of bleeding, 
and no bleeding was detected when the chest was 
inspected after the animal was put to death. 
Atrial defibrillation data. Tables I and II de- 
scribe the values obtained at the minimum threshold 
voltage and after an increase in the minimum mean 
threshold voltage of approximately 25%, as tested, 
to determine the percent of successful conversion 
from atrial fibrillation to normal sinus rhythm in 
each study. The animals were tested in the conscious 
Table I. Values obtained at the minimum threshold 
voltage (MTV) for atrial fibrillation 
Conversion to 
MTV Impedance Energy sinus rhythm 
Animal No. (volts) (ohms) (joule) (%) 
1 100 67 0.33 45 
2 110 71 0.38 35 
3 110 58 0.41 75 
4 140 62 0.67 40 
5 100 85 0.30 50 
Mean~ SEM 112± 7 68 ± 4 0.42 ± 0.07 49 
SEM, Standard error of the mean. 
state and tolerated the shock deliveries well. Each 
animal was tested a minimum of 40 times between 
evaluation of the minimum threshold voltage and a 
25% increase in the minimum threshold voltage. 
Intravenous edation was adequate to control any 
potential discomfort. At the mean minimum thresh- 
old voltage of 112 +_ 7 volts, the mean energy 
needed to convert atrial fibrillation to sinus rhythm 
was 0.42 +_ 0.07 joule, the mean impedance was 
68 _ 4 ohms, and the percent of successful conver- 
sion to sinus rhythm at this mean shock energy was 
49%. When the mean minimum threshold voltage 
was increased by 25% to a mean of 140 _+ 17 volts, 
the mean shock energy increased to 0.66 _+ 0.19 
joule, but the mean impedance remained approxi- 
mately the same at 67 -+ 4 ohms. However, the rate 
of conversion increased to 73%. 
Discussion 
This study demonstrates that in the model of 
sterile pericarditis with atrial fibrillation, successful 
atrial defibrillation could be safely achieved at very 
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MTV Impedance Energy rhythm 
Animal No. (volts) (ohms) (joule) (%) 
1 120 66 0.48 85 
2 Wire  migrat ion  - -  - -  - -  
3 130 60 0.50 55 
4 190 64 1.24 85 
5 120 78 0.44 65 
Mean± SEM 140± 17 67± 4 0.66 ± 0.04 73 
SEM, Standard error of the mean. 
low energy (0.30 to 0.67 joule) and in reproducible 
fashion by means of temporary defibrillation wire 
electrodes. This observation is consistent with atrial 
defibrillation data from the same sterile pericarditis 
model with electrode catheters placed in the coro- 
nary sinus and right atrial appendage. 16 Further- 
more, the choice of the sterile pericarditis model for 
study is important because pericarditis believed to 
be one of the important factors that predisposes the 
human atria to fibrillate after heart surgical proce- 
dures.a, 17 Thus this model would appear to repre- 
sent a close clinical counterpart for postoperative 
atrial fibrillation in human beings in terms of both 
arrhythmia mechanism and time course is and a 
logical choice for the evaluation of therapies for 
postoperative atrial fibrillation. 
The atrial defibrillation threshold. Unlike ven- 
tricular tachyarrhythmias, trial tachyarrhythmias 
are generally well tolerated for short periods. Thus, 
whereas the need for immediate defibrillation is 
obvious for patients with ventricular fibrillation, 
immediate restoration of sinus rhythm for patients 
who have atrial fibrillation after cardiac operations 
is rarely necessary. This clinical principle governed 
the selection of the minimum threshold voltage, 
because it was not necessary that each shock be 
successful, but that an acceptable conversion rate at 
low-shock energy be achieved. This principle also 
recognized that atrial fibrillation early after cardiac 
operations (within 2 to 3 days of the operation) may 
be successfully converted, but because atrial fibril- 
lation is likely to recur, simply controlling the ven- 
tricular esponse rate may initially be the appropri- 
ate therapy. Nevertheless, ultimate restoration of 
sinus rhythm is necessary to avoid the short-term 
and long-term sequelae associated with this rhythm 
disturbance. Especially because atrial defibrillation 
is elective, defibrillation with epicardial defibrilla- 
tion wire electrodes hould be reliable, safe, and 
well tolerated. In our study, because high-energy 
shocks were not used, the percent of successful 
defibrillations was well below 100%. However, even 
at very low energy (mean <0.5 joule), each episode 
of atrial fibrillation was stopped with virtually every 
other shock (49% converted to sinus rhythm). Be- 
cause immediate defibrillation is not required for 
the management of atrial fibrillation, the goal of 
safe, reliable, and well-tolerated defibrillation was 
met. Whether this would be true in patients i yet to 
be demonstrated. 
Clinical implications. This pilot study demon- 
strates the potential utility of temporary epicardial 
defibrillation wire electrodes in the management of 
atrial fibrillation after cardiac operations inpatients. 
Temporary epicardial wire electrodes placed at the 
time of cardiac surgical procedures and used in both 
the atrial and ventricular positions for diagnosis of 
postoperative arrhythmias is routine in most cardiac 
surgery centers. Using epicardial wires for atrial 
defibrillation is an extension of their widely recog- 
nized utility. Because a significant portion of pa- 
tients are at risk for the development of atrial 
fibrillation after various cardiac surgical procedures, 
they should benefit from placement of defibrillation 
wire electrodes during the operation if low-energy 
atrial defibrillation can be demonstrated to be effec- 
tive, safe, and tolerable. Although low-energy shocks 
have successfully defibrillated the atria in several ani- 
mal models, 13-16' 19 it is not yet clear that shock ener- 
gies as low as 0.5 joule, which have been successful in 
the animal studies, will be successful in patients. 
To date, studies in patients with catheter elec- 
trodes placed in the coronary sinus and the right 
atrium have shown that atrial fibrillation can be 
successfully converted to sinus rhythm with low- 
energy shocks, but these shocks have ranged from 
0.5 to 2 joules or even more. 2°-23 Because it is likely 
that shocks as low as i joule will be felt as unpleas- 
ant in patients, it is uncertain whether this proce- 
dure will be tolerated and, therefore, accepted in 
clinical practice. However, it may be that temporary 
defibrillation wire electrodes, when used in patients 
to defibrillate the atria after heart surgery, may 
permit successful defibrillation with less than 1 
joule. We suggest that further study of temporary 
epicardial atrial defibrillation electrodes i  indicated 
to examine their utility in patients. The population 
undergoing cardiac surgical procedures i at a sig- 
nificant risk for postoperative atrial fibrillation and 
The Journal of Thoracic and 
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could benefit considerably from this therapy in the 
postoperative period. 
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Discussion 
Dr. Leigh I. G. Iverson (Oakland, Calif.). Atrial fibril- 
lation is a common and often distressing arrhythmia with 
potential consequences involving control of the rate, 
possible thromboembolic phenomena, and the loss of 
ventricular augmentation by atrial systole. Among pa- 
tients having cardiac surgery, 25% to 35% have atrial 
fibrillation after the operation. In the general medical 
population it is the most common cause of hospital admis- 
sion for an arrhythmia. Almost one third of these patients 
will require long-term anticoagulation and approximately 
one fourth will require electrical conversion because of 
failure of medication to achieve a more physiologic rhythm. 
Clearly the patient population who can benefit from the 
resumption of a normally conducted atrial beat is large. 
Therefore, the implications of this study have a far greater 
impact than an interesting protocol involving treating a 
group of dogs with induced atrial fibrillation. 
I have a number of comments regarding this study. 
First, the number of dogs is very small, and it is difficult to 
base conclusions on small numbers. Dog atria are smaller 
than normal human atria, and in this protocol they are 
presumably normal. None of these dogs had atriotomies, 
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hypothermia, or cardiopulmonary b pass with the unpre- 
dictable fluid shifts and the variable ischemia associated 
with different methods of cardioplegia. Furthermore, no 
comparison is made to the physiologic onditions een in 
patients who have chronic valvular disease. Atrial fibrilla- 
tion was induced On multiple occasions in these dogs; 
clearly the treatment of acute atrial fibrillation is different 
from the treatment of chronic atrial fibrillation. The 
arrhythmia l sted for seconds or perhaps minutes before 
conversion. We deal with a patient population that may 
have an arrhythmia that is present for hours, perhaps days, 
and sometimes for several weeks. The substrate in the 
human population, therefore, is totally different from the 
one that you described in this experimental model. How 
do you think the information you have obtained transfers 
to human beings who are in a completely different phys- 
iologic and electrophysiologic s tuation? 
Dr. CmoliK In terms of the substrate and the mecha- 
nism, one of the important features of the model is that 
it uses pericarditis to induce atrial fibrillation. Most 
electrophysiologists would agree that this is probably 
the common denominator in patients having atrial 
fibrillation. The mechanism for the development of 
atrial fibrillation in these dogs is a reentry phenome- 
non. I cannot say that it is almost completely identical 
to that in the human heart, because the human atrium 
has not been completely mapped. However, the atrial 
fibrillation seems to start in the lateral wall, and it is a 
reentry phenomenon that is very similar to that in the 
human heart. In terms of the mechanism, we think this 
model is very appropriate. 
I agree that the substrate may be different. The dogs 
were not subjected to bypass, they did not have atriotomy, 
and there was no difference in terms of temperature. 
However, the two species are very similar in terms of the 
mechanism for the development of atrial fibrillation and 
the defibrillation characteristics. 
Dr. Iverson. Dog 2 disappears in your second set of 
data. You said that the atrial leads migrated in this dog. 
You discuss no proarrhythmic potential for these leads, 
but I wonder if that is the reason that the second dog was 
excluded from further study. Other studies, particularly in
sheep, show a potential for ventricular arrhythmias on 
atrial defibrillation i  0.5% to 0.7% of subjects. 
You said that the dogs were conscious but that no dog 
was sedated to the point that it required intubation. In 
human beings defibrillation Causes pain, even at the low 
number of joules often required to convert atrial fibrilla- 
tion. I am unclear both on how much pain control was 
required and on the issue of the proarrhythmic effects of 
defibrillation i  these dogs. 
Dr. Cmolik. In dog 2 the right atrial electrode migrated 
inferiorly. We conducted minimum threshold voltage de- 
terminations in this dog, but we were interested to see why 
the had wire migrated. We subjected the dog to general 
endotracheal anesthesia, opened the sternotomy, and 
examined the dog. We modified our wire protocol inser- 
tion technique at that time. Instead of one stitch through 
the pericardium with Prolene suture (Ethicon, Inc., Som- 
erville, N.J.), we weaved it in with two stitches, and it had 
nothing to do with a proarrhythmic effect. 
The proarrhythmi c effect at atrial defibrillation was 
reported by one of the coauthors, Dr. Ayers, in Circulation 
recently, and the study was done to see exactly what a safe 
interval is so as not to produce the "R on T phenome- 
non." In dogs, an RR interval of more than 280 msec is 
generally safe. Most of our dogs were between 300 and 
400 msec in term s of sensing the RR interval and avoiding 
an R on T phenomenon. In more than 1000 experiments 
in similar dogs, With catheter-induced atrial arrhythmias, 
thoracotomy approaches, and median sternotomies, we 
have had no incidents of ventricular arrhythmias in this 
model based on using a longer RR interval to sense when 
to shock on the R wave. 
Dr. Iverson. Despite these issues, I think it is an 
excellent study. It has demonstrated that low-energy de- 
fibrillation of 0.4 to 0.7 joule delivered in a biphasic 
waveform by means of removable lectrodes appears afe 
and effective. It would suggest hat human studies are 
warranted, particularly for the patient with an acute 
fibrillation after a cardiac operation. It raises the question 
whether this is a potential treatment modality for 
patients who have paroxysmal atrial fibrillation unre- 
lated to the operation. This brings UP a whole series of 
issues of arrhythmia recognition, implantability, pain 
control, and recognition of who is a candidate. I am 
concerned that we do not have adequate data at this 
point to discuss the potential incidence of inducing 
ventricular tachycardia or fibrillation with electrocon- 
version of atrial fibrillation. 
Your paper raises a number of issues that can be 
resolved only by further investigation, including an inves- 
tigation in primates and probably in human subjects. Have 
you done any further studies along this line? In particular, 
have you attempted to use this technique in patients who 
have acute atrial fibrillation during the postoperative 
course? 
Dr. Cmolik. This is currently being submitted before 
our institutional review board. We ar e going to do further 
studies that involve the use of cardiopulmonary b pass. 
We also plan to use the wires to defibrillate atrial flutter 
and rapid atrial pace out of atrial flutter and for general 
pacing in the postoperative period. I think the utility of 
these wires stems from the fact that they can be used for 
routine pacing in patients with bradycardia. I hope they 
can be used for atrial defibrillation and to convert both 
atrial fibrillation and atrial flutter. 
Regarding the pain issue, the dogs were sedated to keep 
them from wandering around the laboratory more than 
for pain control. Studies in Englan d have shown that 
people start to perceive shocks at about 0.5 joule. At 
our minimum threshold voltage we were about 20% 
below that. The whole goal is for this to be a relatively 
well-tolerated procedure. The rhythm is completely 
different from ventricular fibrillation, in which it is 
necessary to restore some sort of hemodynamic stability 
and conduction immediately to that patient. Even if the 
conversion rate is only 10%, if the procedure is well 
tolerated, there is time to convert he arrhythmia using 
very,low-energy shocks. That is the goal of using this 
type of wire. 
